NorthStar Medical Radioisotopes Revenue and Competitors

Claim your profile

Beloit, WI USA

Location

$117.5M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • NorthStar Medical Radioisotopes's estimated annual revenue is currently $46.2M per year.(i)
  • NorthStar Medical Radioisotopes's estimated revenue per employee is $201,000
  • NorthStar Medical Radioisotopes's total funding is $117.5M.

Employee Data

  • NorthStar Medical Radioisotopes has 230 Employees.(i)
  • NorthStar Medical Radioisotopes grew their employee count by 20% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$30.4M1510%N/AN/A
#2
$56.3M280N/AN/AN/A
#3
$0.8M40%N/AN/A
#4
$34M169-8%N/AN/A
#5
$3.2M16N/AN/AN/A
#6
$21.1M105-13%N/AN/A
#7
$2.6M13N/AN/AN/A
#8
$21.1M105-9%N/AN/A
#9
$52.5M26140%$672.1MN/A
#10
$46.2M23020%$117.5MN/A

NorthStar® Medical Radioisotopes is a nuclear medicine technology company dedicated to transforming the ways that medical radioisotopes are produced and distributed around the world. We are committed to providing the United States with reliable and environmentally friendly radioisotope supply solutions to meet the needs of patients and to advance clinical research. Our first product is the FDA-approved RadioGenix® System, a first of its kind, innovative platform technology for the processing of domestically sourced molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), which is currently the most widely used diagnostic radioisotope for medical purposes. Based in Beloit, Wis., NorthStar Medical Radioisotopes, LLC is a wholly-owned subsidiary of NorthStar Medical Technologies, LLC.

keywords:Biotechnology,Healthcare,Hospitality,Medical Devices,Pharmaceuticals

$117.5M

Total Funding

230

Number of Employees

$46.2M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NorthStar Medical Radioisotopes News

2022-04-17 - Radiopharmaceuticals in Nuclear Medicine Market Detailed In New Research Report 2022 | Progenics Pharmaceutica

... in Nuclear Medicine Market Detailed In New Research Report 2022 | Progenics Pharmaceuticals, Inc., NorthStar Medical Radioisotopes LLC,...

2022-04-06 - Global Demand of Radiopharmaceutical Market Size & Share ...

... and strategies are Eczacýbaþý-Monrol Nuclear Products, NorthStar Medical Radioisotopes, Smith & Nephew plc., Lantheus Medical Imaging,...

2022-03-22 - NorthStar Medical Radioisotopes Provides Updates on ...

NorthStar Medical Radioisotopes is a commercial-stage nuclear medicine company that manufactures and distributes diagnostic and therapeutic...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$54.1M2344%N/A
#2
$73.7M2483%N/A
#3
$88.5M29825%N/A
#4
$116.6M5185%N/A
#5
$182.6M5412%N/A